Lupin has launched Desoximetasone Topical Spray, in the US market. It is used for treatment of plaque psoriasis.

In a regulatory filing the company stated, “Lupin’s Desoximetasone Topical Spray, 0.25%, is the generic equivalent of Taro Pharmaceuticals USA Inc.’s Topicort Topical Spray, 0.25%. It is a corticosteroid indicated for the treatment of plaque psoriasis in patients 18 years of age or older.”

Read EquityPandit’s Technical Analysis of Lupin